<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font22 { font-size : 22; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">pain </span>
   <span class="font28">opioid </span>
   <span class="font22">patients </span>
   <span class="font19">chronic </span>
   <span class="font19">participants </span>
   <span class="font18">SCD </span>
   <span class="font18">cell </span>
   <span class="font17">Participants </span>
   <span class="font17">sickle </span>
   <span class="font16">{border-style </span>
   <span class="font16">use </span>
   <span class="font16">opioids </span>
   <span class="font16">px;} </span>
   <span class="font15">#ffffff;} </span>
   <span class="font15">care </span>
   <span class="font15">management </span>
   <span class="font15">reported </span>
   <span class="font15">marijuana </span>
   <span class="font14">access </span>
   <span class="font14">disease </span>
   <span class="font14">participant </span>
   <span class="font14">SCD. </span>
   <span class="font14">epidemic </span>
   <span class="font14">guidelines </span>
   <span class="font14">study </span>
   <span class="font13">April </span>
   <span class="font13">acute </span>
   <span class="font13">opioids. </span>
   <span class="font13">pain, </span>
   <span class="font13">pain. </span>
   <span class="font13">qualitative </span>
   <span class="font13">stated, </span>
   <span class="font13">Accessed </span>
   <span class="font13">adult </span>
   <span class="font13">medical </span>
   <span class="font13">therapy </span>
   <span class="font13">adults </span>
   <span class="font13">lack </span>
   <span class="font13">physician </span>
   <span class="font12">Krishnamurti. </span>
   <span class="font12">Opioid </span>
   <span class="font12">affected </span>
   <span class="font12">perspective </span>
   <span class="font12">physicians </span>
   <span class="font12">prescribing </span>
   <span class="font12">px; </span>
   <span class="font12">treatment </span>
   <span class="font12">using </span>
   <span class="font12">{font-family </span>
   <span class="font12">CDC </span>
   <span class="font12">Disease </span>
   <span class="font12">JAMA </span>
   <span class="font12">National </span>
   <span class="font12">acupuncture </span>
   <span class="font12">alternative </span>
   <span class="font12">associated </span>
   <span class="font12">barriers </span>
   <span class="font12">drug </span>
   <span class="font12">font-size </span>
   <span class="font12">health </span>
   <span class="font12">including </span>
   <span class="font12">interviews </span>
   <span class="font12">nonopioid </span>
   <span class="font12">prescriptions </span>
   <span class="font12">research </span>
   <span class="font12">American </span>
   <span class="font12">Med. </span>
   <span class="font12">Open </span>
   <span class="font12">Qualitative </span>
   <span class="font12">Sickle </span>
   <span class="font12">analysis </span>
   <span class="font12">comprehensive </span>
   <span class="font12">data </span>
   <span class="font12">disease. </span>
   <span class="font12">dosage </span>
   <span class="font12">double; </span>
   <span class="font12">effects </span>
   <span class="font12">long-term </span>
   <span class="font12">management. </span>
   <span class="font12">state </span>
   <span class="font12">used </span>
   <span class="font11">Health </span>
   <span class="font11">Netw </span>
   <span class="font11">Pain </span>
   <span class="font11">believed </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">coding </span>
   <span class="font11">concerns </span>
   <span class="font11">did </span>
   <span class="font11">increased </span>
   <span class="font11">likely </span>
   <span class="font11">manage </span>
   <span class="font11">national </span>
   <span class="font11">nonpharmacological </span>
   <span class="font11">prescription </span>
   <span class="font11">review </span>
   <span class="font11">solid; </span>
   <span class="font11">therapies. </span>
   <span class="font11">therapy. </span>
   <span class="font11">they’re </span>
   <span class="font11">treat </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">./jamanetworkopen.. </span>
   <span class="font11">African </span>
   <span class="font11">Blood </span>
   <span class="font11">Cell </span>
   <span class="font11">Centers </span>
   <span class="font11">Control </span>
   <span class="font11">Institute </span>
   <span class="font11">I’m </span>
   <span class="font11">Medicaid </span>
   <span class="font11">Medical </span>
   <span class="font11">Pain. </span>
   <span class="font11">State </span>
   <span class="font11">United </span>
   <span class="font11">adverse </span>
   <span class="font11">agreement </span>
   <span class="font11">analysis, </span>
   <span class="font11">benefits </span>
   <span class="font11">bold </span>
   <span class="font11">care. </span>
   <span class="font11">collab: </span>
   <span class="font11">conditions </span>
   <span class="font11">content </span>
   <span class="font11">conversations </span>
   <span class="font11">courier; </span>
   <span class="font11">decreased </span>
   <span class="font11">em; </span>
   <span class="font11">evidence </span>
   <span class="font11">experience </span>
   <span class="font11">focus </span>
   <span class="font11">goals </span>
   <span class="font11">hydromorphone </span>
   <span class="font11">increasing </span>
   <span class="font11">insurance </span>
   <span class="font11">interview </span>
   <span class="font11">interviewed </span>
   <span class="font11">like </span>
   <span class="font11">limited </span>
   <span class="font11">multimodality </span>
   <span class="font11">nonpharmacologic </span>
   <span class="font11">participants’ </span>
   <span class="font11">patient </span>
   <span class="font11">person </span>
   <span class="font11">preoccupation </span>
   <span class="font11">pt;} </span>
   <span class="font11">recommend </span>
   <span class="font11">recruited </span>
   <span class="font11">risks </span>
   <span class="font11">sample </span>
   <span class="font11">social </span>
   <span class="font11">stigmatization </span>
   <span class="font11">time </span>
   <span class="font11">view </span>
  </p>
 </body>
</html>
